dc.contributor.author |
Benadie, Y
|
|
dc.contributor.author |
Semete, B
|
|
dc.contributor.author |
Venter, L
|
|
dc.contributor.author |
Kalombo, Lonji
|
|
dc.contributor.author |
Driver, C
|
|
dc.contributor.author |
Jones, AT
|
|
dc.contributor.author |
Swai, H
|
|
dc.contributor.author |
Verschoor, JA
|
|
dc.date.accessioned |
2008-12-12T12:32:41Z |
|
dc.date.available |
2008-12-12T12:32:41Z |
|
dc.date.issued |
2008-11 |
|
dc.identifier.citation |
Benadie, Y, Semete, B, Venter, L et al. 2008. Nanoencapsulation of mycolic acids as a deliverable to macrophages. Science Real and Relevant: 2nd CSIR Biennial Conference, CSIR International Convention Centre Pretoria, 17 & 18 November 2008, pp 1 |
en |
dc.identifier.uri |
http://hdl.handle.net/10204/2746
|
|
dc.description |
Science Real and Relevant: 2nd CSIR Biennial Conference, CSIR International Convention Centre Pretoria, 17 & 18 November 2008 |
en |
dc.description.abstract |
The objective of this project was to explore the encapsulation of mycolic acids into vehicles other than liposomes for delivery into macrophages and addressing the challenges of low solubility. As vehicles nanoparticles (NP) have the advantage over liposomes in that they can increase the stability of the drug as well as effect controlled release of the agent as a function of in vivo particle degradation. |
en |
dc.language.iso |
en |
en |
dc.publisher |
CSIR |
en |
dc.subject |
Mycolic acids |
en |
dc.subject |
Macrophages |
en |
dc.subject |
Asthma |
en |
dc.subject |
Tuberculosis |
en |
dc.title |
Nanoencapsulation of mycolic acids as a deliverable to macrophages - 2nd CSIR Biennial Conference |
en |
dc.type |
Conference Presentation |
en |
dc.identifier.apacitation |
Benadie, Y., Semete, B., Venter, L., Kalombo, L., Driver, C., Jones, A., ... Verschoor, J. (2008). Nanoencapsulation of mycolic acids as a deliverable to macrophages - 2nd CSIR Biennial Conference. CSIR. http://hdl.handle.net/10204/2746 |
en_ZA |
dc.identifier.chicagocitation |
Benadie, Y, B Semete, L Venter, Lonji Kalombo, C Driver, AT Jones, H Swai, and JA Verschoor. "Nanoencapsulation of mycolic acids as a deliverable to macrophages - 2nd CSIR Biennial Conference." (2008): http://hdl.handle.net/10204/2746 |
en_ZA |
dc.identifier.vancouvercitation |
Benadie Y, Semete B, Venter L, Kalombo L, Driver C, Jones A, et al, Nanoencapsulation of mycolic acids as a deliverable to macrophages - 2nd CSIR Biennial Conference; CSIR; 2008. http://hdl.handle.net/10204/2746 . |
en_ZA |
dc.identifier.ris |
TY - Conference Presentation
AU - Benadie, Y
AU - Semete, B
AU - Venter, L
AU - Kalombo, Lonji
AU - Driver, C
AU - Jones, AT
AU - Swai, H
AU - Verschoor, JA
AB - The objective of this project was to explore the encapsulation of mycolic acids into vehicles other than liposomes for delivery into macrophages and addressing the challenges of low solubility. As vehicles nanoparticles (NP) have the advantage over liposomes in that they can increase the stability of the drug as well as effect controlled release of the agent as a function of in vivo particle degradation.
DA - 2008-11
DB - ResearchSpace
DP - CSIR
KW - Mycolic acids
KW - Macrophages
KW - Asthma
KW - Tuberculosis
LK - https://researchspace.csir.co.za
PY - 2008
T1 - Nanoencapsulation of mycolic acids as a deliverable to macrophages - 2nd CSIR Biennial Conference
TI - Nanoencapsulation of mycolic acids as a deliverable to macrophages - 2nd CSIR Biennial Conference
UR - http://hdl.handle.net/10204/2746
ER -
|
en_ZA |